Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia.
Branella GM, Lee JY, Okalova J, Parwani KK, Alexander JS, Arthuzo RF, Fedanov A, Yu B, McCarty D, Brown HC, Chandrakasan S, Petrich BG, Doering CB, Spencer HT.
Branella GM, et al. Among authors: alexander js.
Front Immunol. 2023 Nov 13;14:1294555. doi: 10.3389/fimmu.2023.1294555. eCollection 2023.
Front Immunol. 2023.
PMID: 38022523
Free PMC article.